Dr. Fong joined ADARx as our Chief Medical Officer with more than two decades of experience in clinical trials, clinical development and healthcare organizations. He previously served as Chief Medical Officer at BioCryst Pharmaceuticals. Prior positions include VP/Head of Ophthalmology at Annexon Biosciences, and Director of Clinical Trials and Research at Kaiser Permanente Southern California. Dr. Fong received his BA from Pomona College, his MD from UT Health San Antonio and his MPH from Harvard School of Public Health. He served his residency and fellowships in ophthalmology at Harvard Medical School/Mass General Brigham/Mass Eye and Ear, followed by fellowships at NIH.
